Congratulations to Sichuan Neautus Traditional Chinese Medicine Co., Ltd.(2206.HK) on its successful Listing on the Mainboard of HKSE on 11 November 2026.
Sichuan Neautus Traditional Chinese Medicine Co., Ltd. is a large-scale traditional Chinese medicine decoction-ready products provider in China. It serves a broad range of institutional and retail clients — including hospitals and medical institutions, medical trading companies, pharmacies, pharmaceutical companies, and more recently, individual consumers — with traditional herbal preparations, wellness products, and health management services.
With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services on the expected credit loss assessment of the financial assets and the incremental borrowing rate assessment.
Congratulations again Sichuan Neautus Traditional Chinese Medicine Co., Ltd.(2206.HK) on its successful listing. The issue price of the shares is HKD 40.20 per share, and the amount of funds raised is HKD 262 million.
Meet Our People

JOJO HU
Senior Manager
VALUATION ADVISORY
jojo.hu@avaval.com
Date: 11 Nov 2026 | Tags: Business Valuation
AVISTA is collaborating with Anderson Global in China